Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL4241086 | 0.98 | PARP1 (0.66) | PARP1KCNH2 | |
| SCHEMBL4252874 | 0.94 | PARP1 (0.78) | PARP1 | |
| SCHEMBL20544662 | 0.89 | PARP1 (0.68) | PARP1 | |
| SCHEMBL19005624 | 0.88 | PARP1 (0.88) | PARP1KCNH2 | |
| Trifluoroacetic Acid SCHEMBL4247765 | 0.88 | PARP1 (0.65) | PARP1 | |
| Trifluoroacetic Acid SCHEMBL4248736 | 0.88 | PARP1 (0.67) | PARP1 | |
| SCHEMBL3985679 | 0.87 | PARP1 (0.71) | PARP1 | |
| SCHEMBL19005726 | 0.87 | PARP1 (0.75) | PARP1KCNH2 | |
| Trifluoroacetic Acid SCHEMBL3922864 | 0.86 | PARP1 (0.61) | PARP1 | |
| SCHEMBL20544671 | 0.86 | PARP1 (0.63) | PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2029551-B1 | PYRIDINONE AND PYRIDAZINONE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) | MSD ITALIA SRL (IT) | 2018-10-31 | — | — | EP | claimed |
| EP-2029551-A2 | PYRIDINONE AND PYRIDAZINONE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 2009-03-04 | — | — | EP | disclosed |
| WO-2007138351-A2 | PYRIDINONE AND PYRIDAZINONE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) | 2007-12-06 | — | — | WO | disclosed |